Skip to main content
. Author manuscript; available in PMC: 2014 Dec 1.
Published in final edited form as: Nutr Clin Pract. 2013 Oct 25;28(6):684–690. doi: 10.1177/0884533613507607

Table 3.

Placebo-Controlled Randomized Trials Reporting the Effects of Protein Supplementation on Muscle Mass, Strength and/or Physical Performance among adults over 65*

Supplement
Type
Dose Reference Study Population Duration Muscle
Mass
Outcomes*
Muscle Strength
Outcomes
Physical
Performance
Outcomes
Milk protein 2 15-g (MPC80; milk protein concentrate), 7.1 g lactose, 0.5g fat, 0.4 g calcium or matching placebo (Friesland) Tieland 201231 65 frail men and women aged 65 and older 24 wk DXA (NS) Leg-press, leg-extension (NS) SPPB (↑)
Leucine 7.5g/d L-Leucine (Frutarom) or placebo (wheat flour; Verstegen) as capsules with meals Leenders 201149 60 men with type 2 diabetes (mean age 71±1y) 24 wk DXA (NS) Leg-press, leg-extension (↑ Frutaro) NA
7.5 g/d L-Leucine (Ajinomoto) or placebo (wheat flour; Verstegen) as capsules with meals Verhoeven et al 200950 30 healthy men (mean age 71±4y) 12 wk DXA (NS) Leg-press, leg-extension (NS) NA
Juven** Juven** vs NEAA powder with breakfast Baier 200943 129 men and women from senior centers 1 yr BIA (FFM ↑ with Juven) and DXA (NS) Knee extension; hand grip (NS) Get-up-and-Go (NS)
Juven** vs NEAA powder with breakfast Flakoll 200451 29 women in study 1 (age 65–90); 28 women in study 2 (62 to 85) 12 wk BIA (NS) Knee extension (↑); hand grip (↑) Get-up-and-Go ↑
EAA 2 7.5g EAA or placebo capsules Dillon 200933 14 women (mean age 69) 12 wk DXA ↑ Knee extension; hand grip (NS) NA
*

Includes studies having a placebo control group, targeting prevention of sarcopenia (rather than treatment), and involved nutrition intervention alone (rather than in combination with exercise).

**

Juven is comprised of HMB (CaHMB, 2 or 3 g), L-arginine (5 or 7.5 g), L-lysine (lysine HCl, 1.5 or 2.25 g), and ascorbic acid (0.1 g).Participants were assigned to the lower or higher dose based on a weight cutpoint (68 kg). The control group received a similar orange-tasting isonitrogenous and isocaloric drink consisting of a mixture of nonessential amino acids (alanine 5.6 g, glutamic acid 0.9 g,glycine 3.1 g, serine 2.2 g and containing 0.1 g of ascorbic acid, and matched with the treatment based on net weight of the packet content

Abbreviations: ↑ or NS (non-significant)= intervention compared to controls ;AA=amino acid supplement; BIA= Bioelectrical impedance analysis; DXA= dual x-ray absorpitmetry ; EAA=essential amino acid; E=Exercise; FFM=fat free mass; NA=not applicable; SPPB: Short Physical Performance Battery